Literature DB >> 31893993

Mathematical Modeling to Address Challenges in Pancreatic Cancer.

Prashant Dogra1, Javier R Ramírez1, María J Peláez1,2, Zhihui Wang1, Vittorio Cristini1, Gulshan Parasher3, Manmeet Rawat3.   

Abstract

Pancreatic Ductal Adenocarcinoma (PDAC) is regarded as one of the most lethal cancer types for its challenges associated with early diagnosis and resistance to standard chemotherapeutic agents, thereby leading to a poor five-year survival rate. The complexity of the disease calls for a multidisciplinary approach to better manage the disease and improve the status quo in PDAC diagnosis, prognosis, and treatment. To this end, the application of quantitative tools can help improve the understanding of disease mechanisms, develop biomarkers for early diagnosis, and design patient-specific treatment strategies to improve therapeutic outcomes. However, such approaches have only been minimally applied towards the investigation of PDAC, and we review the current status of mathematical modeling works in this field. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Cancer; Carcinoembryoniczzm321990Antigen (CEA); Desmoplasia; Mathematical modeling; Numerical simulation; Pancreatic ductal adenocarcinoma.

Year:  2020        PMID: 31893993      PMCID: PMC7279939          DOI: 10.2174/1568026620666200101095641

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  59 in total

1.  Morphologic instability and cancer invasion.

Authors:  Vittorio Cristini; Hermann B Frieboes; Robert Gatenby; Sergio Caserta; Mauro Ferrari; John Sinek
Journal:  Clin Cancer Res       Date:  2005-10-01       Impact factor: 12.531

Review 2.  Pancreatic adenocarcinoma.

Authors:  David P Ryan; Theodore S Hong; Nabeel Bardeesy
Journal:  N Engl J Med       Date:  2014-09-11       Impact factor: 91.245

Review 3.  Mathematical modeling of cancer progression and response to chemotherapy.

Authors:  Sandeep Sanga; John P Sinek; Hermann B Frieboes; Mauro Ferrari; John P Fruehauf; Vittorio Cristini
Journal:  Expert Rev Anticancer Ther       Date:  2006-10       Impact factor: 4.512

4.  Transport properties of pancreatic cancer describe gemcitabine delivery and response.

Authors:  Eugene J Koay; Mark J Truty; Vittorio Cristini; Ryan M Thomas; Rong Chen; Deyali Chatterjee; Ya'an Kang; Priya R Bhosale; Eric P Tamm; Christopher H Crane; Milind Javle; Matthew H Katz; Vijaya N Gottumukkala; Marc A Rozner; Haifa Shen; Jeffery E Lee; Huamin Wang; Yuling Chen; William Plunkett; James L Abbruzzese; Robert A Wolff; Gauri R Varadhachary; Mauro Ferrari; Jason B Fleming
Journal:  J Clin Invest       Date:  2014-03-10       Impact factor: 14.808

5.  Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer.

Authors:  Eugene J Koay; Flavio E Baio; Alexander Ondari; Mark J Truty; Vittorio Cristini; Ryan M Thomas; Rong Chen; Deyali Chatterjee; Ya'an Kang; Joy Zhang; Laurence Court; Priya R Bhosale; Eric P Tamm; Aliya Qayyum; Christopher H Crane; Milind Javle; Matthew H Katz; Vijaya N Gottumukkala; Marc A Rozner; Haifa Shen; Jeffrey E Lee; Huamin Wang; Yuling Chen; William Plunkett; James L Abbruzzese; Robert A Wolff; Anirban Maitra; Mauro Ferrari; Gauri R Varadhachary; Jason B Fleming
Journal:  Phys Biol       Date:  2014-11-26       Impact factor: 2.583

Review 6.  The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates.

Authors:  Katherine E Poruk; D Z Gay; K Brown; J D Mulvihill; K M Boucher; C L Scaife; M A Firpo; S J Mulvihill
Journal:  Curr Mol Med       Date:  2013-03       Impact factor: 2.222

7.  Mechanistic patient-specific predictive correlation of tumor drug response with microenvironment and perfusion measurements.

Authors:  Jennifer Pascal; Elaine L Bearer; Zhihui Wang; Eugene J Koay; Steven A Curley; Vittorio Cristini
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-12       Impact factor: 11.205

8.  Impact of diffusion barriers to small cytotoxic molecules on the efficacy of immunotherapy in breast cancer.

Authors:  Hiranmoy Das; Zhihui Wang; M Khalid Khan Niazi; Reeva Aggarwal; Jingwei Lu; Suman Kanji; Manjusri Das; Matthew Joseph; Metin Gurcan; Vittorio Cristini
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

9.  Precancerous neoplastic cells can move through the pancreatic ductal system.

Authors:  Alvin P Makohon-Moore; Karen Matsukuma; Ming Zhang; Johannes G Reiter; Jeffrey M Gerold; Yuchen Jiao; Lisa Sikkema; Marc A Attiyeh; Shinichi Yachida; Corinne Sandone; Ralph H Hruban; David S Klimstra; Nickolas Papadopoulos; Martin A Nowak; Kenneth W Kinzler; Bert Vogelstein; Christine A Iacobuzio-Donahue
Journal:  Nature       Date:  2018-09-03       Impact factor: 69.504

Review 10.  Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches.

Authors:  Michael Orth; Philipp Metzger; Sabine Gerum; Julia Mayerle; Günter Schneider; Claus Belka; Maximilian Schnurr; Kirsten Lauber
Journal:  Radiat Oncol       Date:  2019-08-08       Impact factor: 3.481

View more
  5 in total

Review 1.  Image-guided mathematical modeling for pharmacological evaluation of nanomaterials and monoclonal antibodies.

Authors:  Prashant Dogra; Joseph D Butner; Sara Nizzero; Javier Ruiz Ramírez; Achraf Noureddine; María J Peláez; Dalia Elganainy; Zhen Yang; Anh-Dung Le; Shreya Goel; Hon S Leong; Eugene J Koay; C Jeffrey Brinker; Vittorio Cristini; Zhihui Wang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-04-21

2.  A Mathematical Model to Estimate Chemotherapy Concentration at the Tumor-Site and Predict Therapy Response in Colorectal Cancer Patients with Liver Metastases.

Authors:  Daniel A Anaya; Prashant Dogra; Zhihui Wang; Mintallah Haider; Jasmina Ehab; Daniel K Jeong; Masoumeh Ghayouri; Gregory Y Lauwers; Kerry Thomas; Richard Kim; Joseph D Butner; Sara Nizzero; Javier Ruiz Ramírez; Marija Plodinec; Richard L Sidman; Webster K Cavenee; Renata Pasqualini; Wadih Arap; Jason B Fleming; Vittorio Cristini
Journal:  Cancers (Basel)       Date:  2021-01-25       Impact factor: 6.639

3.  Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma Exhibit Differential Growth and Metabolic Patterns in the Pre-Diagnostic Period: Implications for Early Detection.

Authors:  Mohamed Zaid; Dalia Elganainy; Prashant Dogra; Annie Dai; Lauren Widmann; Pearl Fernandes; Zhihui Wang; Maria J Pelaez; Javier R Ramirez; Aatur D Singhi; Anil K Dasyam; Randall E Brand; Walter G Park; Syed Rahmanuddin; Michael H Rosenthal; Brian M Wolpin; Natalia Khalaf; Ajay Goel; Daniel D Von Hoff; Eric P Tamm; Anirban Maitra; Vittorio Cristini; Eugene J Koay
Journal:  Front Oncol       Date:  2020-12-02       Impact factor: 5.738

4.  Translational Modeling Identifies Synergy between Nanoparticle-Delivered miRNA-22 and Standard-of-Care Drugs in Triple-Negative Breast Cancer.

Authors:  Prashant Dogra; Javier Ruiz Ramírez; Joseph D Butner; Maria J Peláez; Caroline Chung; Anupama Hooda-Nehra; Renata Pasqualini; Wadih Arap; Vittorio Cristini; George A Calin; Bulent Ozpolat; Zhihui Wang
Journal:  Pharm Res       Date:  2022-03-16       Impact factor: 4.200

5.  A mathematical model to predict nanomedicine pharmacokinetics and tumor delivery.

Authors:  Prashant Dogra; Joseph D Butner; Javier Ruiz Ramírez; Yao-Li Chuang; Achraf Noureddine; C Jeffrey Brinker; Vittorio Cristini; Zhihui Wang
Journal:  Comput Struct Biotechnol J       Date:  2020-02-29       Impact factor: 7.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.